318 related articles for article (PubMed ID: 27121846)
41. Probiotic yogurt for the treatment of minimal hepatic encephalopathy.
Bajaj JS; Saeian K; Christensen KM; Hafeezullah M; Varma RR; Franco J; Pleuss JA; Krakower G; Hoffmann RG; Binion DG
Am J Gastroenterol; 2008 Jul; 103(7):1707-15. PubMed ID: 18691193
[TBL] [Abstract][Full Text] [Related]
42. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy.
Saji S; Kumar S; Thomas V
Trop Gastroenterol; 2011; 32(2):128-32. PubMed ID: 21922877
[TBL] [Abstract][Full Text] [Related]
43. Effect of different treatments and alcohol addiction on gut microbiota in minimal hepatic encephalopathy patients.
Zuo Z; Fan H; Tang XD; Chen YM; Xun LT; Li Y; Song ZJ; Zhai HQ
Exp Ther Med; 2017 Nov; 14(5):4887-4895. PubMed ID: 29201193
[TBL] [Abstract][Full Text] [Related]
44. Pharmacotherapy of hepatic encephalopathy in cirrhosis.
Romero-Gómez M
Expert Opin Pharmacother; 2010 Jun; 11(8):1317-27. PubMed ID: 20384539
[TBL] [Abstract][Full Text] [Related]
45. Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis.
Zhao LN; Yu T; Lan SY; Hou JT; Zhang ZZ; Wang SS; Liu FB
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):674-82. PubMed ID: 25956487
[TBL] [Abstract][Full Text] [Related]
46. Gut microbiota: its role in hepatic encephalopathy.
Rai R; Saraswat VA; Dhiman RK
J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S29-36. PubMed ID: 26041954
[TBL] [Abstract][Full Text] [Related]
47. Combination therapy for the treatment and prevention of hepatic encephalopathy.
Mohammad RA; Regal RE; Alaniz C
Ann Pharmacother; 2012 Nov; 46(11):1559-63. PubMed ID: 23092866
[TBL] [Abstract][Full Text] [Related]
48. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
49. Hepatic encephalopathy: Ever closer to its big bang.
Souto PA; Marcotegui AR; Orbea L; Skerl J; Perazzo JC
World J Gastroenterol; 2016 Nov; 22(42):9251-9256. PubMed ID: 27895414
[TBL] [Abstract][Full Text] [Related]
50. Microbiome therapeutics for hepatic encephalopathy.
Bloom PP; Tapper EB; Young VB; Lok AS
J Hepatol; 2021 Dec; 75(6):1452-1464. PubMed ID: 34453966
[TBL] [Abstract][Full Text] [Related]
51. Management options for minimal hepatic encephalopathy.
Bajaj JS
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):785-90. PubMed ID: 19090738
[TBL] [Abstract][Full Text] [Related]
52. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
53. Management of overt hepatic encephalopathy.
Sharma P; Sharma BC
J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S82-7. PubMed ID: 26041964
[TBL] [Abstract][Full Text] [Related]
54. Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver.
Dhiman RK; Saraswat VA; Sharma BK; Sarin SK; Chawla YK; Butterworth R; Duseja A; Aggarwal R; Amarapurkar D; Sharma P; Madan K; Shah S; Seth AK; Gupta RK; Koshy A; Rai RR; Dilawari JB; Mishra SP; Acharya SK;
J Gastroenterol Hepatol; 2010 Jun; 25(6):1029-41. PubMed ID: 20594216
[TBL] [Abstract][Full Text] [Related]
55. Treatment of Overt Hepatic Encephalopathy.
Sussman NL
Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
[TBL] [Abstract][Full Text] [Related]
56. Dietary management of hepatic encephalopathy revisited.
Amodio P; Canesso F; Montagnese S
Curr Opin Clin Nutr Metab Care; 2014 Sep; 17(5):448-52. PubMed ID: 25025262
[TBL] [Abstract][Full Text] [Related]
57. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review.
Schulz C; Schütte K; Malfertheiner P
J Clin Gastroenterol; 2014 Jul; 48(6):491-9. PubMed ID: 24583758
[TBL] [Abstract][Full Text] [Related]
58. Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota.
Garcovich M; Zocco MA; Roccarina D; Ponziani FR; Gasbarrini A
World J Gastroenterol; 2012 Dec; 18(46):6693-700. PubMed ID: 23239905
[TBL] [Abstract][Full Text] [Related]
59. L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses.
Butterworth RF; McPhail MJW
Drugs; 2019 Feb; 79(Suppl 1):31-37. PubMed ID: 30706425
[TBL] [Abstract][Full Text] [Related]
60. What is new about diet in hepatic encephalopathy.
Merli M; Iebba V; Giusto M
Metab Brain Dis; 2016 Dec; 31(6):1289-1294. PubMed ID: 26419384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
